Evidence map›Paper›PMID 30338056›Full record

ArticleIrish veterinary journal2018

Effect of l-theanine tablets in reducing stress-related emotional signs in cats: an open-label field study.

V Dramard, L Kern, J Hofmans, C A Rème, C S Nicolas, V Chala, C Navarro

Open access · goldAbstract read
In one paragraph

Article in Irish veterinary journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Effect ofIBRO neuroscience reports · 2025
    Article
  4. Article
  5. Article
  6. Dietary Strategies for Relieving Stress in Pet Dogs and Cats.Antioxidants (Basel, Switzerland) · 2023
    Review
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

V DramardReferral Behaviour Veterinary Clinic, 16 rue Jeanne d'Arc, 69003 Lyon, France.
L KernReferral Behaviour Veterinary Clinic, 6 place Léon Deubel, 75016 Paris, France.
J HofmansVeterinary Clinic, Avenue des Martyrs 173, 4620 Fléron, Belgium.
C A Rème4Medical Department, Virbac, 13ème rue, LID, 06511 Carros, France.
C S Nicolas4Medical Department, Virbac, 13ème rue, LID, 06511 Carros, France.
V Chala4Medical Department, Virbac, 13ème rue, LID, 06511 Carros, France.ORCID 0000-0002-7142-0155
C Navarro4Medical Department, Virbac, 13ème rue, LID, 06511 Carros, France.
Virbac (France) · FRHôpital Jeanne d'Arc · FRMartel · CHUniversidad de León · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundL-theanine is an aminoacid found in tea leaves which has relaxing effects in humans and animals. It is a structural analogue of glutamate which can bind glutamate receptors. Although the relaxing action of L-theanine has been shown in humans, laboratory animals and dogs, it has never been published in cats. The goal of this open-label, multicentre and prospective trial was to determine whether an L-theanine based oral supplement (Anxitane®, Virbac, France) could attenuate manifestations of stress in cats under field conditions. CASE PRESENTATION: Thirty-three privately owned cats presenting signs associated with stress or fear (inappropriate urination/defecation, fear-induced aggressiveness, hypervigilance/tenseness or physical/functional manifestations of stress) for at least 1 month, were included in the study. They were given L-theanine (Anxitane®, 25 mg twice a day) for 30 days and 20 stress-related parameters were scored at Days 0, 15 and 30. The evolution of some parameters was also rated relative to Day 0. All median scores of the 20 parameters were significantly reduced at D30, and 30/33 cats (91%) had a reduced global score at the end of the study, including 21/33 with ≥50% score reduction. The median (IQR) global scores went from 18 (13-23) at D0 to 11 (8-13) at D15 and 5 (3-12) at D30 (

conclusionsDespite the lack of a placebo group, it can be concluded that L-theanine (Anxitane®) helped to improve the undesirable manifestations of stress in cats in as soon as 15 days, though better results could be seen after 30 days of administration. These encouraging results show that L-theanine can help manage stress-related behaviour, but additional trials with a placebo group should be run to confirm this effect.

Indexed as

Anxitane®CatsFieldL-theanineStressUndesirable behaviours

Identifiers

PMID30338056
PMCPMC6178259
OpenAlexW2897371146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.